Vivus (VVUS)

Add to Watchlists
Create an Alert
5.36 +0.11  +2.10% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
VVUS Price Chart
View All Events

VVUS Events

Date Type Description
Feb 24 Misc Vivus Q4 2013 Earning Conference Call
Feb 24 Earnings Vivus Q4 2013 Earning Result. Estimate: -0.43.
Nov 05 Misc Vivus Announces Date of Third Quarter 2013 Financial Results and Conference Call
Nov 05 Earnings Vivus Third Quarter 2013 Results. Estimate: -0.38.
Aug 06 Misc Vivus Announces Date of Second Quarter 2013 Financial Results and Conference Call
Aug 06 Earnings Vivus Second Quarter 2013 Results. Estimate: -0.49.
Jul 15 Misc AGM Event for Vivus Inc
May 08 Misc VIVUS Announces Date of First Quarter 2013 Financial Results and Conference Call
May 08 Earnings Vivus First Quarter 2013 Results. Estimate: -0.52.
View All Performance Charts

VVUS Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Vivus is down 54.58% over the last year vs S&P 500 Total Return up 20.96%, Arena Pharmaceuticals down 23.33%, and Eisai down 11.49%.

Get Quote for

PDF Report for VVUS

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download VVUS Pro Report PDF
Advertisement

Portfolio Strategies Featuring VVUS

Did Vivus make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

VVUS Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Vivus is a small pharmaceutical company working in obesity, sleep, and sexual health. Vivus is developing an erectile dysfunction drug, Avanafil, that is in Phase 3 clinical trials. A documentary movie "Orgasm Inc." was made at Vivus in 2009 to document the process of creating a treatment for Female sexual arousal disorder. VIVUS, Inc. has a licensing agreement with Mitsubishi Tanabe Pharma Corporation for the development and commercialization of Avanafil. The company was founded by Virgil A Place on April 16, 1991 and is headquartered in Mountain View, California.

Recent Quotes

Symbol Price Chg Chg % Market Cap
VVUS 5.36 +0.11 +2.10% 552.66M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.